← Back to Search
Sphingosine 1-Phosphate Receptor 1 Signaling In Mammalian Cells
N. Pyne, S. Pyne
Published 2017 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The bioactive lipid, sphingosine 1-phosphate (S1P) binds to a family of G protein-coupled receptors, termed S1P1-S1P5. These receptors function in, for example, the cardiovascular system to regulate vascular barrier integrity and tone, the nervous system to regulate neuronal differentiation, myelination and oligodendrocyte/glial cell survival and the immune system to regulate T- and B-cell subsets and trafficking. S1P receptors also participate in the pathophysiology of autoimmunity, inflammatory disease, cancer, neurodegeneration and others. In this review, we describe how S1P1 can form a complex with G-protein and β-arrestin, which function together to regulate effector pathways. We also discuss the role of the S1P1-Platelet derived growth factor receptor β functional complex (which deploys G-protein/β-arrestin and receptor tyrosine kinase signaling) in regulating cell migration. Possible mechanisms by which different S1P-chaperones, such as Apolipoprotein M-High-Density Lipoprotein induce biological programmes in cells are also described. Finally, the role of S1P1 in health and disease and as a target for clinical intervention is appraised.
This paper references
Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
O. Goodman (1996)
The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis.
S. Laporte (1999)
The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis
S. Laporte (1999)
Molecular Determinants Underlying the Formation of Stable Intracellular G Protein-coupled Receptor-β-Arrestin Complexes after Receptor Endocytosis*
R. H. Oakley (2001)
Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells.
F. Alderton (2001)
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
J. Chun (2002)
Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2*
S. Mukherjee (2002)
Dual Regulation of EDG1/S1P1 Receptor Phosphorylation and Internalization by Protein Kinase C and G-protein-coupled Receptor Kinase 2*
K. Watterson (2002)
International Union of Pharmacology
J. Chun (2002)
Human substance P receptor lacking the C‐terminal domain remains competent to desensitize and internalize
M. D. Richardson (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
Huijun Wei (2003)
Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
Huijun Wei (2003)
Sphingosine 1-Phosphate and Platelet-derived Growth Factor (PDGF) Act via PDGFβ Receptor-Sphingosine 1-Phosphate Receptor Complexes in Airway Smooth Muscle Cells*
C. Waters (2003)
FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function
V. Brinkmann (2004)
c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
C. Waters (2005)
Phosphorylation-independent β-Arrestin Translocation and Internalization of Leukotriene B4 Receptors*
V. Jala (2005)
Transactivation of CXCR4 by the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Human MDA-MB-231 Breast Cancer Epithelial Cells*
C. Akekawatchai (2005)
Divergent behavioral roles of angiotensin receptor intracellular signaling cascades.
D. Daniels (2005)
TRANSACTIVATION OF CXCR 4 BY IGF-1 R IN HUMAN MDA-MB-231 BREAST CANCER EPITHELIAL CELLS
C. Akekawatchai (2005)
c-Src is involved in regulating signal transmission from PDGFβ receptor-GPCR signal complexes in mammalian cells
C. Waters (2005)
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
K. LaMontagne (2006)
The effect of RGS12 on PDGFbeta receptor signalling to p42/p44 mitogen activated protein kinase in mammalian cells.
B. Sambi (2006)
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells.
Z. Chen (2006)
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
I. Ivanov (2006)
The functional PDGFβ receptor–S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor
J. Long (2006)
Cell migration activated by platelet‐derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1‐phosphate receptor‐1
C. Waters (2006)
The effect of RGS12 on platelet derived growth factor beta receptor signaling to p42/p44 MAPK in mammalian cells
B. S. Sambi (2006)
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL - 17 + T helper
I. I. Ivanov (2006)
PACAP type I receptor transactivation is essential for IGF‐1 receptor signalling and antiapoptotic activity in neurons
N. Delcourt (2007)
Regulation of receptor trafficking by GRKs and arrestins.
C. C. Moore (2007)
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano (2007)
Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate1
J. Liao (2007)
STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells*
X. Yang (2007)
Protein Kinase C-ϵ Regulates Sphingosine 1-Phosphate-mediated Migration of Human Lung Endothelial Cells through Activation of Phospholipase D2, Protein Kinase C-ζ, and Rac1*
I. Gorshkova (2008)
A Novel Sphingosine 1-Phosphate Receptor Agonist, 2-Amino-2-propanediol Hydrochloride (KRP-203), Regulates Chronic Colitis in Interleukin-10 Gene-Deficient Mice
J. Song (2008)
Filamin A Links Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 1 at Lamellipodia To Orchestrate Cell Migration
M. Maceyka (2008)
Protein kinase C - epsilon regulates sphingosine 1 - phosphate - mediated migration of human lung endothelial cells through activation of phospholipase D 2 , protein kinase C - zeta , and Rac 1
I. Gorshkova (2008)
Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase
I. Gorshkova (2008)
Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
D. Calebiro (2009)
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.
F. Mullershausen (2009)
Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.
S. Caballero (2009)
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.
S. Ferrandon (2009)
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes*
N. Kobayashi (2009)
The receptor S1P 1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR
G Liu (2009)
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR
G. Liu (2009)
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
C. Watson (2010)
S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
N. Bergelin (2010)
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study
A. Tufail (2010)
S1P1 receptor directs the release of immature B cells from bone marrow into blood
M. L. Allende (2010)
Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors
H. Lee (2010)
S1P1 and VEGFR-2 Form a Signaling Complex with Extracellularly Regulated Kinase 1/2 and Protein Kinase C-α Regulating ML-1 Thyroid Carcinoma Cell Migration
N. Bergelin (2010)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling (2010)
Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?
N. Pyne (2011)
Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.
P. Usatyuk (2011)
Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis
Yasuaki Sanada (2011)
Translational aspects of sphingosine 1-phosphate biology.
S. Pyne (2011)
β-Arrestin-mediated receptor trafficking and signal transduction.
S. Shenoy (2011)
Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration
Roger A. Sabbadini (2011)
Crystal Structure of the β2Adrenergic Receptor-Gs protein complex
S. Rasmussen (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
C. Christoffersen (2011)
HDL and sphingosine‐1‐phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion
Y. Sekine (2011)
cancer DU 145 cells via ERK 1 / 2 and S 1 P receptors , and promote cell migration and invasion
J. Liang (2011)
Crystal Structure of a Lipid G Protein–Coupled Receptor
M. Hanson (2012)
Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells
Y. Hisano (2012)
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner
Georgina Galicia-Rosas (2012)
The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.
K. Gaengel (2012)
S1P1 inhibits sprouting angiogenesis during vascular development
Adi Ben Shoham (2012)
Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier
Brent A. Wilkerson (2012)
A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent
G. Galicia-Rosas (2012)
A sphingosine1 - phosphate receptor 1directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic celldependent manner
G. Galicia-Rosas (2012)
Defective sphingosine-1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
Christopher S Garris (2013)
Sphingosine 1-phosphate is a missing link between chronic inflammation and colon cancer.
N. Pyne (2013)
Conformational biosensors reveal GPCR signalling from endosomes
R. Irannejad (2013)
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Gregory T Kunkel (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
H. Noda (2013)
Noncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin*
T. Feinstein (2013)
Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1
C. Rutherford (2013)
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.
J. Liang (2013)
Individual variation of human S1P1 coding sequence leads to heterogeneity in receptor function and drug interactions[S]
Hideru Obinata (2014)
Second generation S1P pathway modulators: research strategies and clinical developments.
M. Bigaud (2014)
Dynamin 2–dependent endocytosis is required for sustained S1PR1 signaling
T. Willinger (2014)
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
Andrea Vaclavkova (2014)
Molecular and physiological functions of sphingosine 1-phosphate transporters.
T. Nishi (2014)
Effect of Ceralifimod (ONO-4641), a Sphingosine-1-Phosphate Receptor-1 and -5 Agonist, on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis: Interim Results from the Extension of the DreaMS Study (P3.161)
A. Bar-Or (2014)
Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
T. Olsson (2014)
Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo.
M. Kono (2014)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Y. Kihara (2014)
Angiogenesis and Cardiac Hypertrophy: Maintenance of Cardiac Function and Causative Roles in Heart Failure
T. Oka (2014)
S1P signaling: new therapies and opportunities
P. Gonzalez-Cabrera (2014)
Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.
J. Ryu (2014)
Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1
P. Tamashiro (2014)
Visualization of arrestin recruitment by a G Protein-Coupled Receptor
A. Shukla (2014)
Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor
P. M. Tamashiro (2014)
Phase 2 results of the RADIANCE trial: A randomised, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis (LB1.1)
J. A. Cohen (2014)
Visualisation of arrestin recruitment by a G-protein-coupled receptor
A. K. Shukla (2014)
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.
L. Patrussi (2015)
A map of the distribution of sphingosine 1-phosphate in the spleen
W. D. Ramos-Pérez (2015)
HDL-bound sphingosine 1-phosphate restrains lymphopoiesis and neuroinflammation
V. Blaho (2015)
Sphingosine-1-phosphate receptor 1 transmits estrogens’ effects in endothelial cells
O. Sukocheva (2015)
IL-17–Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
Y. Maeda (2015)
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation
S. Galvani (2015)
H. Horiuchi (2015)
Intracellular sphingosine kinase 2‐derived sphingosine‐1‐phosphate mediates epidermal growth factor‐induced ezrin‐radixin‐moesin phosphorylation and cancer cell invasion
Mohamad M. Adada (2015)
S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness
Alejandra Chavez (2015)
Spinster 2, a sphingosine‐1‐phosphate transporter, plays a critical role in inflammatory and autoimmune diseases
Michael S Donoviel (2015)
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
L. Kappos (2016)
Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity
F. Scott (2016)
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.
Bi-sen Ding (2016)
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
A. R. Thomsen (2016)
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination
D. Dukala (2016)
Endocytosis of Ligand‐Activated Sphingosine 1‐Phosphate Receptor 1 Mediated by the Clathrin‐Pathway
P. Reeves (2016)
Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer
P. Bouquerel (2016)
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Fuyang Zhang (2016)
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
W. Sandborn (2016)
Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/syndecan-1/TGF-β autocrine loop
Y. Zeng (2016)
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development.
H. Clay (2016)
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
L. V. D. Weyden (2017)
PACAP type 1 receptor transactivation is essential for IGF-1 receptor signaling and anti-apoptotic activity in neurons
N. Delcourt (2017)
Sphingosine 1-phosphate and cancer.
N. Pyne (2018)
HDL and sphingosine - 1 - phosphate activate stat 3 in
S 1 P 1 inhibits sprouting angiogenesis during vascular
A. Ben Shoham
This paper is referenced by
Research developments in the syntheses, anti-inflammatory activities and structure–activity relationships of pyrimidines
H. Rashid (2021)
No-D quantitative 1H Nuclear Magnetic Resonance spectroscopy method for the determination of ethanol in distilled spirits
Harriet Jane R. Caleja-Ballesteros (2021)
Network pharmacology-based analysis for unraveling potential cancer-related molecular targets of Egyptian propolis phytoconstituents accompanied with molecular docking and in vitro studies
Reham S Ibrahim (2021)
Development of larvicide nanoemulsion from the essential oil of Aeollanthus suaveolens Mart. ex Spreng against Aedes aegypti, and its toxicity in non-target organism
Rosany Lopes Martins (2021)
Solution size variation of linear and dendritic bis-MPA analogs using DOSY-1H NMR
Oluwapelumi O. Kareem (2021)
Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development
B. Caballol (2021)
Oilseed by-products as plant-based protein sources: Amino acid profile and digestibility
A. G. A. Sá (2021)
Essential Oils as Potential Antimicrobial Agents
Disha Varijakzhan (2021)
Recent advances of smart acid-responsive gold nanoparticles in tumor therapy.
Yumin Zhang (2020)
The wonderful and masterful G protein-coupled receptor (GPCR): A focus on signaling mechanisms and the neuroendocrine control of fertility
A. Babwah (2020)
Determinants of Serum- and Plasma Sphingosine-1-Phosphate Concentrations in a Healthy Study Group
G. Daum (2020)
Phytochemical Screening, Antimicrobial and Antioxidant Activities of Selected Mangrove Species
Nilesh Lakshman Dahibhate (2020)
UPLC-UV Method for the Quantification of Free Amino Acids, Bioactive Amines, and Ammonia in Fresh, Cooked, and Canned Mushrooms
G. C. L. Reis (2020)
Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release.
X. Li (2020)
Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii
K. Chiba (2020)
Mitochondrial sphingosine-1-phosphate lyase is essential for phosphatidylethanolamine synthesis and survival of Trypanosoma brucei
Ladan Dawoody Nejad (2020)
Ponesimod for the treatment of relapsing multiple sclerosis
E. Baldin (2020)
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
E. McGowan (2020)
Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment
W. Wang (2020)
Post-translational modifications of S1PR1 and endothelial barrier regulation.
Mumtaz Anwar (2020)
The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders
P. Giussani (2020)
Preparation, spectroscopic study of Schiff base derived from dopamine and metal Ni(II), Pd(II), and Pt(IV) complexes, and activity determination as antioxidants
May J. Kareem (2020)
Introduction to Nanomedicine in Drug Delivery
Tejashri Chavan (2020)
RNA-sequencing based gene expression landscape of guava cv. Allahabad Safeda and comparative analysis to colored cultivars
Amandeep Mittal (2020)
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects
J. Chun (2020)
Nanomedicines in Drug Delivery from Synthetic and Natural Sources to Their Clinical Applications
L. R. Singha (2020)
Emerging Technologies in Algal Biotechnology: Toward the Establishment of a Sustainable, Algae-Based Bioeconomy
M. Fabris (2020)
Thermal-Sprayed Photocatalytic Coatings for Biocidal Applications: A Review
Y. Liu (2020)
GPCRs in innate and adaptive immune responses
G. Dubyak (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
Daniel J. Baillache (2020)
Proton Nuclear Magnetic Resonance‐Based Method for the Quantification of Epoxidized Methyl Oleate
Avneet Kaur (2020)
Synergistic antimicrobial effects of activated lactoferrin and rosemary extract in vitro and potential application in meat storage
F. Soyer (2020)See more